The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation

Por Sobrero, Alberto
Publicado no ESMO Open (2017)

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016

Por Dittrich, C., Kosty, M., Jezdic, S., Pyle, D., Berardi, R., Bergh, J., El Saghir, N., Lotz, J.-P., Österlund, P., Pavlidis, N., Purkalne, G.
Publicado no Ann Oncol (2016)

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

Por Colombo, Nicoletta, Creutzberg, Carien, Amant, Frederic, Bosse, Tjalling, González-Martín, Antonio, Ledermann, Jonathan, Marth, Christian, Nout, Remi, Querleu, Denis, Mirza, Mansoor Raza, Sessa, Cristiana
Publicado no Int J Gynecol Cancer (2016)

ESMO Women for Oncology 2016: a very personal tale of my professional life in Asia

Por Thongprasert, Sumitra
Publicado no ESMO Open (2017)

Reply to Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Por Bracale, Umberto, Sodo, Maurizio, Merola, Giovanni, Di Salvo, Enrico
Publicado no ESMO Open (2016)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

Por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado em 2014

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Por Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., Carey, L., Corneliussen-James, D., Curigliano, G., Dieras, V., El Saghir, N., Eniu, A., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Gennari, A., Harbeck, N., Hudis, C., Kaufman, B., Krop, I., Mayer, M., Meijer, H., Mertz, S., Ohno, S., Pagani, O., Papadopoulos, E., Peccatori, F., Penault-Llorca, F., Piccart, M. J., Pierga, J. Y., Rugo, H., Shockney, L., Sledge, G., Swain, S., Thomssen, C., Tutt, A., Vorobiof, D., Xu, B., Norton, L., Winer, E.
Publicado no Ann Oncol (2017)

Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015

Por Rolfo, Christian, Caglevic, Christian, Bretel, Denisse, Hong, David, Raez, Luis E, Cardona, Andres F, Oton, Ana B, Gomez, Henry, Dafni, Urania, Vallejos, Carlos, Zielinski, Christoph
Publicado no ESMO Open (2016)

Nursing highlights from the 2015 European Cancer Congress (ECCO18–ESMO40), 25–29 September 2015, Vienna: reinforcing multidisciplinarity

Por Caruso, Rosario, Lichosik, Danuta
Publicado no Ecancermedicalscience (2015)

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study

Por Hantson, Inge, Dooms, Christophe, Verbeken, Eric, Vandenberghe, Peter, Vliegen, Liesbet, Roskams, Tania, Borght, Sara Vander, Nackaerts, Kris, Wauters, Isabelle, Vansteenkiste, Johan
Publicado em 2014

Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Por Davies, Will
Publicado no Ecancermedicalscience (2016)

Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort

Por Burris, Howard A, Bakewell, Suzanne, Bendell, Johanna C, Infante, Jeffrey, Jones, Suzanne F, Spigel, David R, Weiss, Glen J, Ramanathan, Ramesh K, Ogden, Angela, Von Hoff, Daniel
Publicado no ESMO Open (2017)

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients...

Por Morgillo, Floriana, Fasano, Morena, Della Corte, Carminia Maria, Sasso, Ferdinando Carlo, Papaccio, Federica, Viscardi, Giuseppe, Esposito, Giovanna, Di Liello, Raimondo, Normanno, Nicola, Capuano, Annalisa, Berrino, Liberato, Vicidomini, Giovanni, Fiorelli, Alfonso, Santini, Mario, Ciardiello, Fortunato
Publicado no ESMO Open (2017)

S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non...

Por Baba, Hideo, Yamada, Yasuhide, Takahari, Daisuke, Matsumoto, Hiroshi, Yoshida, Kazuhiro, Nakamura, Masato, Yoshida, Motoki, Iwamoto, Shigeyoshi, Shimada, Ken, Komatsu, Yoshito, Sasaki, Yasutsuna, Satoh, Taroh, Takahashi, Keiichi, Mishima, Hideyuki, Muro, Kei, Watanabe, Masahiko, Sakata, Yuh, Morita, Satoshi, Shimada, Yasuhiro, Sugihara, Kenichi
Publicado no ESMO Open (2017)

The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical U...

Por Kiesewetter, Barbara, Raderer, Markus, Prager, Gerald W, Fuereder, Thorsten, Marosi, Christine, Preusser, Matthias, Krainer, Michael, Locker, Gottfried J, Brodowicz, Thomas, Zielinski, Christoph C
Publicado no ESMO Open (2017)

In the literature: April 2017

Por Cervantes, Andrés
Publicado no ESMO Open (2017)

Cancer drugs, survival and ethics: a critical look from the inside

Por Piccart, Martine, Pondé, Noam
Publicado no ESMO Open (2017)

In the literature: February 2017

Por Cervantes, Andrés, Terol, María José
Publicado no ESMO Open (2017)

A new era of oncology through artificial intelligence

Por Curioni-Fontecedro, Alessandra
Publicado no ESMO Open (2017)

Biologics and biosimilars: what, why and how?

Por Chan, Juliana CN, Chan, Anthony TC
Publicado no ESMO Open (2017)